Unrecognized Tax Benefits of Elicio Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Elicio Therapeutics, Inc. quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Elicio Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $4,141,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

Elicio Therapeutics, Inc. Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $4,141,000 $0 0% 31 Dec 2025 10-K 12 Mar 2026 2025 FY
Q4 2024 $4,141,000 $0 0% 31 Dec 2024 10-K 12 Mar 2026 2025 FY
Q4 2023 $4,141,000 -$166,000 -3.9% 31 Dec 2023 10-K 12 Mar 2026 2025 FY
Q4 2022 $4,307,000 +$632,000 +17% 31 Dec 2022 10-K 17 Mar 2023 2022 FY
Q4 2021 $3,675,000 +$1,096,000 +42% 31 Dec 2021 10-K 17 Mar 2023 2022 FY
Q4 2020 $2,579,000 +$2,579,000 31 Dec 2020 10-K 17 Mar 2023 2022 FY
Q4 2019 $0 31 Dec 2019 10-K 30 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.